ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
2.620
+0.240 (10.08%)
At close: Jul 8, 2025, 4:00 PM
2.580
-0.040 (-1.53%)
After-hours: Jul 8, 2025, 7:58 PM EDT
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $6.25 million as of July 8, 2025. Its market cap has increased by 35.62% in one year.
Market Cap
6.25M
Enterprise Value
3.87M
1-Year Change
35.62%
Ranking
Category
Stock Price
$2.62
Market Cap Chart
Since January 25, 2019, ReShape Lifesciences's market cap has increased from $2.57M to $6.25M, an increase of 143.48%. That is a compound annual growth rate of 14.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 700.84B |
Johnson & Johnson | 375.37B |
AbbVie | 334.34B |
Novo Nordisk | 316.33B |
UnitedHealth Group | 279.90B |
Novartis AG | 242.35B |
Abbott Laboratories | 233.90B |
AstraZeneca | 218.65B |